TY - JOUR
T1 - Amitriptyline produces multiple influences on the peripheral enhancement of nociception by P2X receptors
AU - Waldron, James B.
AU - Reid, Allison R.
AU - Sawynok, Jana
N1 - Funding Information:
This work was supported by the Canadian Institutes of Health Research.
PY - 2004/9/24
Y1 - 2004/9/24
N2 - Peripherally administered amitriptyline exhibits potential to be a locally active analgesic, while ATP augments peripheral nociception by interacting with P2X 3 receptors on sensory afferents. The present study examined the effects of amitriptyline on flinching and biting/licking behaviours and thermal hyperalgesia produced by αβ-methylene-ATP (αβ-MeATP), a ligand for P2X 3 receptors, following intraplantar administration into the hindpaw of rats. Coadministration of low doses of amitriptyline (up to 100 nmol) with αβ-MeATP augmented thermal hyperalgesia and flinching behaviours. The most active dose of amitriptyline (100 nmol) had no intrinsic effect. Augmentation of αβ-MeATP actions appears to be due to increased tissue levels of biogenic amines resulting from inhibition of uptake, as phentolamine (α 1/α 2-adrenergic receptor antagonist) and methysergide (5-hydroxytryptamine or 5-HT 1/5-HT 2 receptor antagonist) inhibit the augmented flinching produced by αβ-MeATP/amitriptyline. When noradrenaline and 5-HT were coadministered with αβ-MeATP (both increase the effect of αβ-MeATP), amitriptyline had no effect on flinching produced by αβ-MeATP/noradrenaline but inhibited flinching produced by αβ-MeATP/5-HT. In the presence of low concentrations of formalin (0.5%, 1%; which also increase the effect αβ-MeATP), amitriptyline inhibited augmented behaviours. Higher doses of amitriptyline (300-1000 nmol) increased thermal thresholds, suppressed thermal hyperalgesia produced by αβ-MeATP, and inhibited flinching produced by αβ-MeATP. Collectively, these results indicate that amitriptyline produces complex influences on peripheral pain signaling by P2X receptors. Lower doses augment nociception by αβ-MeATP (probably by inhibiting noradrenaline and 5-HT uptake) but inhibit αβ-MeATP responses in the presence of inflammatory mediators (perhaps reflecting receptor blocking properties); higher doses uniformly inhibit nociception by αβ-MeATP (perhaps reflecting local anesthetic properties).
AB - Peripherally administered amitriptyline exhibits potential to be a locally active analgesic, while ATP augments peripheral nociception by interacting with P2X 3 receptors on sensory afferents. The present study examined the effects of amitriptyline on flinching and biting/licking behaviours and thermal hyperalgesia produced by αβ-methylene-ATP (αβ-MeATP), a ligand for P2X 3 receptors, following intraplantar administration into the hindpaw of rats. Coadministration of low doses of amitriptyline (up to 100 nmol) with αβ-MeATP augmented thermal hyperalgesia and flinching behaviours. The most active dose of amitriptyline (100 nmol) had no intrinsic effect. Augmentation of αβ-MeATP actions appears to be due to increased tissue levels of biogenic amines resulting from inhibition of uptake, as phentolamine (α 1/α 2-adrenergic receptor antagonist) and methysergide (5-hydroxytryptamine or 5-HT 1/5-HT 2 receptor antagonist) inhibit the augmented flinching produced by αβ-MeATP/amitriptyline. When noradrenaline and 5-HT were coadministered with αβ-MeATP (both increase the effect of αβ-MeATP), amitriptyline had no effect on flinching produced by αβ-MeATP/noradrenaline but inhibited flinching produced by αβ-MeATP/5-HT. In the presence of low concentrations of formalin (0.5%, 1%; which also increase the effect αβ-MeATP), amitriptyline inhibited augmented behaviours. Higher doses of amitriptyline (300-1000 nmol) increased thermal thresholds, suppressed thermal hyperalgesia produced by αβ-MeATP, and inhibited flinching produced by αβ-MeATP. Collectively, these results indicate that amitriptyline produces complex influences on peripheral pain signaling by P2X receptors. Lower doses augment nociception by αβ-MeATP (probably by inhibiting noradrenaline and 5-HT uptake) but inhibit αβ-MeATP responses in the presence of inflammatory mediators (perhaps reflecting receptor blocking properties); higher doses uniformly inhibit nociception by αβ-MeATP (perhaps reflecting local anesthetic properties).
UR - http://www.scopus.com/inward/record.url?scp=4544287801&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4544287801&partnerID=8YFLogxK
U2 - 10.1016/j.ejphar.2004.07.116
DO - 10.1016/j.ejphar.2004.07.116
M3 - Article
C2 - 15381049
AN - SCOPUS:4544287801
SN - 0014-2999
VL - 499
SP - 275
EP - 283
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 3
ER -